|
|
|
|
|
|
|
|
|
|
"Frings said Roche would file for European regulatory approval of Avastin in ovarian cancer by the end of the year, with a U.S. submission following in 2011."
Tuesday, October 05, 2010
financial news: PREVIEW-New cancer data may be tonic for sickly Roche | Reuters
"Frings said Roche would file for European regulatory approval of Avastin in ovarian cancer by the end of the year, with a U.S. submission following in 2011."
Subscribe to:
Post Comments
(
Atom
)
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.